ArticleOncotarget2016

Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.

Julia Onken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.